Geopolitics Alpha

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Published . Updated .

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism HCPLive

Directly affected

  • No company is named in this report.

Indirectly affected

  • XOM Exxon Mobil

    Oil producers earn more when crude prices rise

  • CVX Chevron

    Oil producers earn more when crude prices rise

  • OXY Occidental Petroleum

    Oil producers earn more when crude prices rise

  • COP ConocoPhillips

    Oil producers earn more when crude prices rise

  • VLO Valero

    Refiners' profits move with crude and fuel prices

  • MPC Marathon Petroleum

    Refiners' profits move with crude and fuel prices

  • XOP SPDR S&P Oil & Gas Exploration

    A fund of oil and gas producers

  • XLE Energy Select Sector SPDR

    A fund of energy companies

  • USO United States Oil Fund

    This fund moves with oil prices

  • OIH VanEck Oil Services

    Oilfield services rise when drilling follows oil prices

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
XOM———————
CVX-2.61%-3.22%—+1.43%+2.75%+4.76%+3.48%
OXY-2.97%-3.14%—+1.72%+2.59%+2.20%+0.96%
COP-4.28%-3.18%—+2.57%+5.07%+6.13%+5.67%
VLO———————
MPC-4.71%-2.77%—+0.99%+4.89%+6.56%+4.75%
XOP———————
XLE———————
USO———————
OIH+1.60%-1.76%—+0.08%+0.59%-1.55%-3.03%

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism HCPLive

Source: HCPLive

Price since this story was published: United States Brent Oil Fund (BNO)

Since the first closing price after “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism,” United States Brent Oil Fund (BNO) is +2.99%. The S&P 500 fund (SPY) is -1.47% over the same days, a +4.46% difference versus the market. energy stocks (XLE) is +2.70%, a +0.30% difference versus that group of stocks.

CompanyWhenMoveStatus
COPthat day+2.57%final price
COPthe next day+5.07%final price
COPtwo days later+6.13%final price
COPthree days later+5.67%final price
COPthree days earlier-3.18%final price
COPfive days earlier-4.28%final price
CVXthat day+1.43%final price
CVXthe next day+2.75%final price
CVXtwo days later+4.76%final price
CVXthree days later+3.48%final price
CVXthree days earlier-3.22%final price
CVXfive days earlier-2.61%final price
MPCthat day+0.99%final price
MPCthe next day+4.89%final price
MPCtwo days later+6.56%final price
MPCthree days later+4.75%final price
MPCthree days earlier-2.77%final price
MPCfive days earlier-4.71%final price
OIHthat day+0.08%final price
OIHthe next day+0.59%final price
OIHtwo days later-1.55%final price
OIHthree days later-3.03%final price
OIHthree days earlier-1.76%final price
OIHfive days earlier+1.60%final price
OXYthat day+1.72%final price
OXYthe next day+2.59%final price
OXYtwo days later+2.20%final price
OXYthree days later+0.96%final price
OXYthree days earlier-3.14%final price
OXYfive days earlier-2.97%final price
BNO
SPY
XLE

Who gains and who loses around United States Brent Oil Fund (BNO)

Companies mentioned with this story

  • BNO United States Brent Oil Fund

    United States Brent Oil Fund (BNO) is linked, with no stored direction, high confidence in the 11 Oct 2026 story “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism.” Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • UGA United States Gasoline Fund

    United States Gasoline Fund (UGA) is linked, with no stored direction, high confidence in the 11 Oct 2026 story “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism.” Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • GSG iShares S&P GSCI Commodity-Indexed Trust

    In “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism,” iShares S&P GSCI Commodity-Indexed Trust (GSG) is linked, with no stored direction, high confidence. Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • VDE Vanguard World Fd

    In “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism,” Vanguard World Fd (VDE) is linked, with no stored direction, high confidence. Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • IEZ Ishares U.S. Oil Equipment & Services Etf

    Ishares U.S. Oil Equipment & Services Etf (IEZ) is linked, with no stored direction, high confidence in the 11 Oct 2026 story “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism.” Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • FENY

    For “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism,” FENY is linked, with no stored direction, high confidence. Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • XOP State Street Spdr S&P Oil & Gas Exploration & Production Etf

    For “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism,” State Street Spdr S&P Oil & Gas Exploration & Production Etf (XOP) is linked, with no stored direction, high confidence. Reason on file: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

  • AMLP Alps Etf Tr

    In “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism,” Alps Etf Tr (AMLP) is linked, with no stored direction, medium confidence. Reason on file: Pipeline, terminal, and midstream disruptions can transmit through transport capacity and midstream cash-flow expectations

United States Brent Oil Fund (BNO) and the energy link

On 11 Oct 2026, “Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism” is the story that connects United States Brent Oil Fund (BNO) to Energy.

The link for United States Brent Oil Fund (BNO) is this: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

United States Gasoline Fund (UGA) is here too. Its reason reads: Oil-transport or export disruption can transmit through crude and refined-product prices, energy-producer cash flows, and oil-services activity

Dates and price levels for United States Brent Oil Fund (BNO)

BNO traded between 57.39 and 67.79 across 20 sessions. The latest close on file is 67.10. GSG traded between 35.09 and 37.22 across 10 sessions. The latest close on file is 37.04. UGA traded between 140.00 and 152.81 across 20 sessions. The latest close on file is 143.49.

How strong the case is around United States Brent Oil Fund (BNO)

46 out of 100

“Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism” scores 46 out of 100. The score uses 1 sources, and 14 linked companies.